← Cases
SwitzerlandHealthcare and life sciences2019 – ongoing

Novartis

AI marketing-spend optimization for oncology brands

Novartis used AI-based oncology marketing in 8 markets in 2019

In progressCompany's own claimOfficial ↗

Problem

Novartis sought to optimize marketing spending on oncology brands.

Approach

Novartis applied AI-based marketing to oncology spending decisions. It reported use in 8 markets during 2019.

Results

8markets using AI-based oncology marketing, according to NovartisCompany's own claim[1]

Takeaway

The disclosed figure measured geographic reach. Novartis did not report savings or incremental sales from this application.

Categories

Business function
Marketing and sales
Innovation type
Process innovation
AI technology
Optimization
Evidence
Company's own claim

Sources

  1. Novartis Annual Report 2019
    Novartis29 Jan 2020Company publication

Source summaries

[1]Novartis29 Jan 2020

Novartis reported AI-based marketing to optimize oncology spending in 8 markets. It did not quantify the resulting commercial benefit.

Full details are in the original sources.

Added 1 Nov 2026 · Updated 1 Nov 2026
Open case page ↗